96 related articles for article (PubMed ID: 20451878)
1. The Alzheimer's disease neuroimaging initiative: perspectives of the Industry Scientific Advisory Board.
Schmidt ME; Siemers E; Snyder PJ; Potter WZ; Cole P; Soares H
Alzheimers Dement; 2010 May; 6(3):286-90. PubMed ID: 20451878
[TBL] [Abstract][Full Text] [Related]
2. Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
Liu E; Luthman J; Cedarbaum JM; Schmidt ME; Cole PE; Hendrix J; Carrillo MC; Jones-Davis D; Tarver E; Novak G; De Santi S; Soares HD; Potter WZ; Siemers E; Schwarz AJ
Alzheimers Dement; 2015 Jul; 11(7):840-9. PubMed ID: 26194317
[TBL] [Abstract][Full Text] [Related]
3. The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB).
Albala B; Appelmans E; Burress R; De Santi S; Devins T; Klein G; Logovinsky V; Novak GP; Ribeiro K; Schmidt ME; Schwarz AJ; Scott D; Shcherbinin S; Siemers E; Travaglia A; Weber CJ; White L; Wolf-Rodda J; Vasanthakumar A
Alzheimers Dement; 2024 Jan; 20(1):695-708. PubMed ID: 37774088
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease neuroimaging initiative in Europe.
Frisoni GB
Alzheimers Dement; 2010 May; 6(3):280-5. PubMed ID: 20451877
[TBL] [Abstract][Full Text] [Related]
5. Maximizing the Alzheimer's Disease Neuroimaging Initiative II.
Carrillo MC; Sanders CA; Katz RG
Alzheimers Dement; 2009 May; 5(3):271-5. PubMed ID: 19362888
[TBL] [Abstract][Full Text] [Related]
6. The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update.
Hendrix JA; Finger B; Weiner MW; Frisoni GB; Iwatsubo T; Rowe CC; Kim SY; Guinjoan SM; Sevlever G; Carrillo MC
Alzheimers Dement; 2015 Jul; 11(7):850-9. PubMed ID: 26194318
[TBL] [Abstract][Full Text] [Related]
7. Worldwide Alzheimer's disease neuroimaging initiative.
Carrillo MC; Bain LJ; Frisoni GB; Weiner MW
Alzheimers Dement; 2012 Jul; 8(4):337-42. PubMed ID: 22748939
[TBL] [Abstract][Full Text] [Related]
8. The impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?
Jones-Davis DM; Buckholtz N
Alzheimers Dement; 2015 Jul; 11(7):860-4. PubMed ID: 26194319
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans.
Aisen PS; Petersen RC; Donohue M; Weiner MW;
Alzheimers Dement; 2015 Jul; 11(7):734-9. PubMed ID: 26194309
[TBL] [Abstract][Full Text] [Related]
10. Japanese Alzheimer's Disease Neuroimaging Initiative: present status and future.
Iwatsubo T
Alzheimers Dement; 2010 May; 6(3):297-9. PubMed ID: 20451880
[TBL] [Abstract][Full Text] [Related]
11. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative.
Ellis KA; Rowe CC; Villemagne VL; Martins RN; Masters CL; Salvado O; Szoeke C; Ames D;
Alzheimers Dement; 2010 May; 6(3):291-6. PubMed ID: 20451879
[TBL] [Abstract][Full Text] [Related]
12. [Biomarkers for Alzheimer's disease: after Alzheimer's disease neuroimaging initiative studies].
Shoji M
Brain Nerve; 2012 May; 64(5):497-504. PubMed ID: 22570063
[TBL] [Abstract][Full Text] [Related]
13. Creation of the Argentina-Alzheimer's Disease Neuroimaging Initiative.
Russo MJ; Gustafson D; Vázquez S; Surace E; Guinjoan S; Allegri RF; Sevlever G;
Alzheimers Dement; 2014 Feb; 10(1 Suppl):S84-7. PubMed ID: 24864324
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
Gauthier S; Leuzy A; Racine E; Rosa-Neto P
Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
[TBL] [Abstract][Full Text] [Related]
15. Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).
Buerger K; Frisoni G; Uspenskaya O; Ewers M; Zetterberg H; Geroldi C; Binetti G; Johannsen P; Rossini PM; Wahlund LO; Vellas B; Blennow K; Hampel H
Exp Gerontol; 2009 Sep; 44(9):579-85. PubMed ID: 19539742
[TBL] [Abstract][Full Text] [Related]
16. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
[TBL] [Abstract][Full Text] [Related]
17. Clinical drug trials in Alzheimer disease. What are some of the issues?
Jarvik LF; Berg L; Bartus R; Heston L; Leith N; Phelps C; Shader R; Whitehouse P
Alzheimer Dis Assoc Disord; 1990; 4(4):193-202. PubMed ID: 2264978
[TBL] [Abstract][Full Text] [Related]
18. Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease.
Frank RA; Galasko D; Hampel H; Hardy J; de Leon MJ; Mehta PD; Rogers J; Siemers E; Trojanowski JQ;
Neurobiol Aging; 2003; 24(4):521-36. PubMed ID: 12714109
[No Abstract] [Full Text] [Related]
19. The Alzheimer's Disease Neuroimaging Initiative informatics core: A decade in review.
Toga AW; Crawford KL
Alzheimers Dement; 2015 Jul; 11(7):832-9. PubMed ID: 26194316
[TBL] [Abstract][Full Text] [Related]
20. [Alzheimer's disease Neuroimaging Initiative (ADNI)].
Iwatsubo T
Nihon Rinsho; 2011 Oct; 69 Suppl 8():570-4. PubMed ID: 22787853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
